Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Silent myocardial ischemia]

X Tabone1, C Mounier Vehier, A Vacheron

  • 1Clinique cardiologique, Hôpital Necker, Paris.

Journal Des Maladies Vasculaires
|January 1, 1993
PubMed
Summary

Silent myocardial ischemia (SMI) is a significant risk factor in various patient groups. Its presence indicates poorer prognosis, though optimal treatment strategies for asymptomatic individuals remain under investigation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

["Heart, arteries and women" an innovative care pathway for women at high risk: First evaluation at one year].

Annales de cardiologie et d'angeiologie·2015
Same author

[Primary coronary angioplasty for myocardial infarction--the view of the cardiologic surgeon].

Annales de cardiologie et d'angeiologie·2012
Same author

[The need for information in medicine].

Revue des sciences morales & politiques : travaux de l'Academie des sciences morales et politiques·2008
Same author

Association of eNOS Glu298Asp gene polymorphism with circadian blood pressure rhythm.

Journal of human hypertension·2007
Same author

[Address by Professor A. Vacheron].

Bulletin et memoires de l'Academie royale de medecine de Belgique·2006
Same author

[Prescriptions in cardiology].

Annales pharmaceutiques francaises·2005

Area of Science:

  • Cardiology
  • Internal Medicine
  • Clinical Research

Context:

  • Silent myocardial ischemia (SMI) affects 2-5% of asymptomatic individuals, 25-30% post-myocardial infarction, and 40% with stable angina.
  • Prognosis in coronary insufficiency correlates with the number of stenosed vessels and left ventricular function.
  • SMI presence is an independent risk factor, adding to the overall cardiovascular risk profile.

Purpose:

  • To review the prevalence and prognostic implications of silent myocardial ischemia.
  • To discuss the established benefits of bypass surgery in high-risk patients.
  • To highlight the lack of demonstrated benefits for medical treatment and coronary angioplasty in asymptomatic SMI patients.

Summary:

  • Silent myocardial ischemia (SMI) is prevalent across different cardiac conditions, from asymptomatic individuals to post-myocardial infarction and stable angina patients.
  • While bypass surgery survival benefits are proven for high-risk patients with significant coronary artery disease, the efficacy of medical management and angioplasty for asymptomatic SMI is not yet established.
  • SMI is an additive risk factor impacting patient prognosis, independent of traditional markers like ventricular function and vessel stenosis.

Impact:

  • Provides a comprehensive overview of silent myocardial ischemia's prevalence and risk.
  • Clarifies the current evidence base for surgical interventions versus medical or interventional treatments in specific patient cohorts.
  • Underscores the need for further research into optimal management strategies for asymptomatic patients with silent ischemia.

Related Experiment Videos